"Middle East Respiratory Syndrome Coronavirus (MERS-CoV), formerly called "novel coronavirus (nCoV)," was identified in 2012 in Saudi Arabia. Most people who got infected with MERS-CoV developed severe acute respiratory illness with symptoms of fe"...
- Patient Information:
Details with Side Effects
Tonsillitis and/or Pharyngitis
MOXATAG (amoxicillin extended-release tablets) is a penicillin-class antibacterial indicated for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes (S. pyogenes) in adults and pediatric patients 12 yrs and older.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of MOXATAG (amoxicillin extended-release tablets) and other antibacterial drugs, MOXATAG (amoxicillin extended-release tablets) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
DOSAGE AND ADMINISTRATION
Tonsillitis and/or Pharyngitis
The recommended dose of MOXATAG (amoxicillin extended-release tablets) is 775 mg once daily taken within 1 hour of finishing a meal for 10 days. The full 10-day course of therapy should be completed for effective treatment of tonsillitis and/or pharyngitis secondary to S. pyogenes.
Do not chew or crush tablet.
Dosage Forms And Strengths
775 mg blue film-coated, oval-shaped tablets printed with "MB-111" on one side in black edible ink.
MOXATAG (amoxicillin extended-release tablets) tablets for oral administration are provided as blue film- coated, oval-shaped tablets that contain 775 mg of amoxicillin as the trihydrate. The tablets are printed with "MB-111" on one side in black edible ink. MOXATAG (amoxicillin extended-release tablets) is packaged in bottles and blister cards as follows:
- Bottles of 30............................................NDC [11042-###-##]
- 10 Tablet Card (1 tablet per blister cavity)..............NDC [11042-###-##]
Store at 25º C (77º F); excursions permitted to 15-30º C (59-86º F) [See USP Controlled Room Temperature.]
CLINITEST is a registered trademark of Miles, Inc. CLINISTIX is a registered trademark of Bayer Corporation. MOXATAG (amoxicillin extended-release tablets) is a trademark of MiddleBrook Pharmaceuticals, Inc.,MiddleBrook Pharmaceuticals, Inc. Germantown, Maryland 20876 USA. FDA Rev date: 1/23/2008
Last reviewed on RxList: 2/8/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Moxatag Information
Moxatag - User Reviews
Moxatag User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.